• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同的生理机制导致男性和女性不良心血管疾病风险特征不同。

Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.

机构信息

Center for Human Nutrition, Washington University School of Medicine, St. Louis, MO, USA.

出版信息

Proc Nutr Soc. 2020 May;79(2):210-218. doi: 10.1017/S0029665119001022. Epub 2019 Jul 25.

DOI:10.1017/S0029665119001022
PMID:31340878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583670/
Abstract

CVD affect about one-third of the population and are the leading cause of mortality. The prevalence of CVD is closely linked to the prevalence of obesity because obesity is commonly associated with metabolic abnormalities that are important risk factors for CVD, including insulin resistance, pre-diabetes, and type-2 diabetes, atherosclerotic dyslipidaemia, endothelial dysfunction and hypertension. Women have a more beneficial traditional CVD risk profile (lower fasting plasma glucose, less atherogenic lipid profile) and a lower absolute risk for CVD than men. However, the relative risk for CVD associated with hyperglycaemia and dyslipidaemia is several-fold higher in women than in men. The reasons for the sex differences in CVD risk associated with metabolic abnormalities are unclear but could be related to differences in the mechanisms that cause hyperglycaemia and dyslipidaemia in men and women, which could influence the pathogenic processes involved in CVD. In the present paper, we review the influence of a person's sex on key aspects of metabolism involved in the cardiometabolic disease process, including insulin action on endogenous glucose production, tissue glucose disposal, and adipose tissue lipolysis, insulin secretion and insulin plasma clearance, postprandial glucose, fatty acid, and triglyceride kinetics, hepatic lipid metabolism and myocardial substrate use. We conclude that there are marked differences in many aspects of metabolism in men and women that are not all attributable to differences in the sex hormone milieu. The mechanisms responsible for these differences and the clinical implications of these observations are unclear and require further investigation.

摘要

CVD 影响约三分之一的人口,是导致死亡的主要原因。CVD 的患病率与肥胖症的患病率密切相关,因为肥胖症通常与代谢异常有关,而代谢异常是 CVD 的重要危险因素,包括胰岛素抵抗、前驱糖尿病和 2 型糖尿病、动脉粥样硬化性血脂异常、内皮功能障碍和高血压。与男性相比,女性具有更有利的传统 CVD 风险特征(空腹血糖较低,致动脉粥样硬化的血脂谱较少),且 CVD 的绝对风险较低。然而,与高血糖和血脂异常相关的 CVD 风险在女性中的相对风险是男性的数倍。与代谢异常相关的 CVD 风险的性别差异的原因尚不清楚,但可能与导致男性和女性高血糖和血脂异常的机制差异有关,这可能会影响 CVD 相关的致病过程。在本文中,我们回顾了个体性别对涉及心血管代谢疾病过程的代谢关键方面的影响,包括胰岛素对内源性葡萄糖生成、组织葡萄糖摄取和脂肪组织脂肪分解、胰岛素分泌和胰岛素血浆清除、餐后血糖、脂肪酸和甘油三酯动力学、肝脂质代谢和心肌底物利用的影响。我们得出结论,男性和女性在许多代谢方面存在显著差异,这些差异并非全部归因于性激素环境的差异。这些差异的机制以及这些观察结果的临床意义尚不清楚,需要进一步研究。

相似文献

1
Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women.不同的生理机制导致男性和女性不良心血管疾病风险特征不同。
Proc Nutr Soc. 2020 May;79(2):210-218. doi: 10.1017/S0029665119001022. Epub 2019 Jul 25.
2
Lipid metabolism in women.女性的脂质代谢
Proc Nutr Soc. 2004 Feb;63(1):153-60. doi: 10.1079/PNS2003314.
3
Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study.胆汁酸螯合剂对 2 型糖尿病患者糖代谢、肝内从头脂肪生成、胆固醇和胆汁酸动力学的影响:一项随机对照研究。
Diabetologia. 2012 Feb;55(2):432-42. doi: 10.1007/s00125-011-2382-3. Epub 2011 Dec 2.
4
Recurrent hypoglycemia increases hepatic gluconeogenesis without affecting glycogen metabolism or systemic lipolysis in rat.在大鼠中,反复低血糖会增加肝糖异生,而不影响糖原代谢或全身脂肪分解。
Metabolism. 2022 Nov;136:155310. doi: 10.1016/j.metabol.2022.155310. Epub 2022 Sep 3.
5
Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic mice.在链脲佐菌素诱导的糖尿病小鼠中,甘油三酯水平的主要调节因素是脂肪分解,而非肝脏脂肪生成。
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):102-10. doi: 10.1161/ATVBAHA.114.304615. Epub 2014 Nov 13.
6
Associations of insulin-like growth factor binding protein-2 with metabolic profile and hepatic fat deposition in asymptomatic men and women.胰岛素样生长因子结合蛋白-2 与无症状男性和女性代谢特征及肝内脂肪沉积的相关性。
Am J Physiol Endocrinol Metab. 2023 Jul 1;325(1):E99-E105. doi: 10.1152/ajpendo.00108.2023. Epub 2023 Jun 7.
7
Hepatic fatty acid and glucose handling in metabolic disease: Potential impact on cardiovascular disease risk.代谢性疾病中的肝脏脂肪酸和葡萄糖处理:对心血管疾病风险的潜在影响。
Atherosclerosis. 2024 Jul;394:117237. doi: 10.1016/j.atherosclerosis.2023.117237. Epub 2023 Aug 11.
8
Abdominal and femoral adipose tissue lipolysis and cardiovascular disease risk factors in men.男性腹部和股部脂肪组织的脂肪分解与心血管疾病风险因素
Eur J Clin Invest. 1993 Nov;23(11):729-40. doi: 10.1111/j.1365-2362.1993.tb01293.x.
9
Effects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extraction.年龄和性别对餐后葡萄糖代谢的影响:葡萄糖周转率、胰岛素分泌、胰岛素作用及肝脏胰岛素摄取的差异
Diabetes. 2006 Jul;55(7):2001-14. doi: 10.2337/db05-1692.
10
Effect of exenatide on postprandial glucose fluxes, lipolysis, and ß-cell function in non-diabetic, morbidly obese patients.艾塞那肽对非糖尿病病态肥胖患者餐后葡萄糖通量、脂肪分解及β细胞功能的影响。
Diabetes Obes Metab. 2017 Mar;19(3):412-420. doi: 10.1111/dom.12836. Epub 2017 Jan 10.

引用本文的文献

1
Global trends and disparities in ischemic heart disease attributable to high systolic blood pressure, 1990-2021: Insights from the global burden of disease study.1990年至2021年期间,归因于收缩压升高的缺血性心脏病的全球趋势和差异:来自全球疾病负担研究的见解
PLoS One. 2025 Jun 12;20(6):e0324073. doi: 10.1371/journal.pone.0324073. eCollection 2025.
2
The Impact of Diet and Sociodemographic Factors on Cardiovascular Health in University Students.饮食和社会人口学因素对大学生心血管健康的影响
Int J Environ Res Public Health. 2025 May 10;22(5):752. doi: 10.3390/ijerph22050752.
3
How does biological age acceleration mediate the associations of obesity with cardiovascular disease? Evidence from international multi-cohort studies.生物年龄加速如何介导肥胖与心血管疾病之间的关联?来自国际多队列研究的证据。
Cardiovasc Diabetol. 2025 May 14;24(1):209. doi: 10.1186/s12933-025-02770-0.
4
Optimal Cut-off Points of the Standardized Continuous Metabolic Syndrome Severity Score (cMetS-S) for Predicting Cardiovascular Disease (CVD) and CVD Mortality in the Tehran Lipid and Glucose Study (TLGS).德黑兰血脂与血糖研究(TLGS)中用于预测心血管疾病(CVD)及CVD死亡率的标准化连续代谢综合征严重程度评分(cMetS-S)的最佳切点
Int J Endocrinol Metab. 2024 Dec 18;22(4):e154255. doi: 10.5812/ijem-154255. eCollection 2024 Oct.
5
Differences in risk factor profiles for peripheral artery disease compared to coronary, cerebral and carotid artery.与冠状动脉、脑动脉和颈动脉相比,外周动脉疾病风险因素概况的差异。
Sci Rep. 2025 Jan 31;15(1):3864. doi: 10.1038/s41598-025-88516-0.
6
Usefulness of Atherogenic Indices for Predicting High Values of Avoidable Lost Life Years Heart Age in 139,634 Spanish Workers.致动脉粥样硬化指数对预测139634名西班牙工人中可避免的生命损失年数和心脏年龄高值的有用性。
Diagnostics (Basel). 2024 Oct 26;14(21):2388. doi: 10.3390/diagnostics14212388.
7
Distribution of Arteriosclerotic Vessels in Patients with Arteriosclerosis and the Differences of Serum Lipid Levels Classified by Different Sites.动脉硬化患者中动脉硬化血管的分布及不同部位分类的血脂水平差异
Int J Gen Med. 2024 Oct 16;17:4733-4744. doi: 10.2147/IJGM.S483324. eCollection 2024.
8
Gender Differences in Prevalence and Associated Factors of Dyslipidemia in Initial-Treatment and Drug-Naïve Schizophrenia Patients.初治及未用药精神分裂症患者血脂异常患病率及相关因素的性别差异
Neuropsychiatr Dis Treat. 2024 May 8;20:957-966. doi: 10.2147/NDT.S457631. eCollection 2024.
9
Characterization of sexual dimorphism in ANGPTL4 levels and function.血管生成素样蛋白4(ANGPTL4)水平及功能的性别差异特征分析
J Lipid Res. 2024 Apr;65(4):100526. doi: 10.1016/j.jlr.2024.100526. Epub 2024 Feb 29.
10
Sex-Specific Differences in Lipoprotein Production and Clearance.脂蛋白生成和清除的性别特异性差异。
Arterioscler Thromb Vasc Biol. 2023 Sep;43(9):1617-1625. doi: 10.1161/ATVBAHA.122.318247. Epub 2023 Jul 6.

本文引用的文献

1
Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.非空腹血脂检测时代的餐后高甘油三酯血症再探讨:2019 年专家小组声明,叙述性综述。
Curr Vasc Pharmacol. 2019;17(5):515-537. doi: 10.2174/1570161117666190503123911.
2
Triglycerides and cardiovascular risk: Apolipoprotein B holds the key.甘油三酯与心血管风险:载脂蛋白B是关键。
Atherosclerosis. 2019 May;284:221-222. doi: 10.1016/j.atherosclerosis.2019.03.004. Epub 2019 Mar 21.
3
Challenging metabolic tissues with fructose: tissue-specific and sex-specific responses.用果糖挑战代谢组织:组织特异性和性别特异性反应。
J Physiol. 2019 Jul;597(14):3527-3537. doi: 10.1113/JP277115. Epub 2019 Apr 2.
4
Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease.载脂蛋白脂蛋白脂酶基因 Triglyceride-Lowering LPL 变异体与 LDL 受体基因 LDL-C-Lowering LDLR 变异体与冠心病风险的相关性研究。
JAMA. 2019 Jan 29;321(4):364-373. doi: 10.1001/jama.2018.20045.
5
The Evolving Story of Triglycerides and Coronary Heart Disease Risk.甘油三酯与冠心病风险的演变历程
JAMA. 2019 Jan 29;321(4):347-349. doi: 10.1001/jama.2018.20044.
6
Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.非糖尿病成人和青少年中初级胰岛素分泌过多的识别、病理生理学和临床意义。
JCI Insight. 2018 Dec 20;3(24):124912. doi: 10.1172/jci.insight.124912.
7
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.全球、区域和国家按年龄、性别和死因分类的死亡率,195 个国家和地区,1980-2017 年:2017 年全球疾病负担研究的系统分析。
Lancet. 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7. Epub 2018 Nov 8.
8
Sex Differences in Glucose and Fatty Acid Metabolism in Asians Who Are Nonobese.非肥胖亚洲人群的葡萄糖和脂肪酸代谢的性别差异。
J Clin Endocrinol Metab. 2019 Jan 1;104(1):127-136. doi: 10.1210/jc.2018-01421.
9
Sex Differences in Hepatic Lipogenesis with Acute Fructose Feeding.急性果糖喂养导致的肝脂生成中的性别差异。
Nutrients. 2018 Sep 7;10(9):1263. doi: 10.3390/nu10091263.
10
Mechanisms of Insulin Action and Insulin Resistance.胰岛素作用机制和胰岛素抵抗。
Physiol Rev. 2018 Oct 1;98(4):2133-2223. doi: 10.1152/physrev.00063.2017.